Antisense & RNAi Therapeutics Market Size, Share And Growth Analysis For 2024-2033
Antisense & RNAi Therapeutics Global Market Report 2024
The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033
LONDON, GREATER LONDON, UK, May 14, 2024 /EINPresswire.com/ -- The global market reports from The Business Research Company have been updated with the most recent market sizing data for 2024 and projections extended to 2033
The Business Research Company’s “Antisense & RNAi Therapeutics Global Market Report 2024 is a comprehensive source of information that covers every facet of the market. As per TBRC’s market forecast, the antisense & rnai therapeutics market size is predicted to reach $2.81 billion in 2028 at a compound annual growth rate (CAGR) of 12.3%.
The growth in the antisense & rnai therapeutics market is due to the rising prevalence of coronary artery diseases, neurodegenerative disorders, and infectious diseases. North America region is expected to hold the largest antisense & rnai therapeutics market share. Major players in the antisense & rnai therapeutics market include Biogen Inc., Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Moderna Inc., Sanofi S.A.,.
Antisense & RNAi Therapeutics Market Segments
• By Technology: RNA Interference, Antisense RNA
• By Route of Administration: Intravenous Injections, Intra-dermal Injections, Other Delivery Methods
• By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications
• By Geography: The global antisense & rnai therapeutics market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Learn More On The Market By Requesting A Free Sample (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=3389&type=smp
Antisense therapy refers to the selective, sequence-specific suppression of gene expression by single-stranded DNA oligonucleotides. Contrarily, RNA interference (RNAi) is activated by double-stranded RNA (dsRNA) and results in the sequence-specific mRNA degradation of single-stranded target RNAs.
Read More On The Antisense & RNAi Therapeutics Global Market Report At:
https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Antisense & RNAi Therapeutics Market Characteristics
3. Antisense & RNAi Therapeutics Market Trends And Strategies
4. Antisense & RNAi Therapeutics Market – Macro Economic Scenario
5. Antisense & RNAi Therapeutics Market Size And Growth
……
27. Antisense & RNAi Therapeutics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Market
29. Antisense & RNAi Therapeutics Market Future Outlook and Potential Analysis
30. Appendix
Browse Through More Similar Reports By The Business Research Company:
Alzheimer’s Disease Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report
Pharmaceutical Sterility Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testings-global-market-report
Neurodegenerative Disorder Therapeutics Global Market Report 2024 https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report
Contact Information
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn
YouTube
Oncology Biomarkers Market
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
